A carregar...
Targeting PCSK9 for therapeutic gains
Even though it is only a little over a decade from the discovery of proprotein convertase subtilisin/kexin type 9 (PCSK9) as a plasma protein that associates with both hypercholesterolemia and low cholesterol syndromes, a rich literature has developed describing its unique physiology and the impact...
Na minha lista:
| Publicado no: | Curr Atheroscler Rep |
|---|---|
| Main Authors: | , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
2015
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5560054/ https://ncbi.nlm.nih.gov/pubmed/25712137 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s11883-015-0499-4 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|